Literature DB >> 35720780

A Rare Case of Guillain-Barré Syndrome Associated With SARS-CoV-2 Infection Requiring Mechanical Ventilation.

Rahul Prakash Rane1, Ashish Jain1, Khandakar M Hussain1, Sarvesh Naik1, Asna Shahab1.   

Abstract

Coronavirus disease 2019 (COVID-19) has become a worldwide pandemic since the first case of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection was identified in December 2019. Numerous neurological consequences have been reported with COVID-19 infection and its approved vaccines. However, Guillain-Barré syndrome (GBS) is a rare neurological complication associated with COVID-19 infection. This case report describes a 62-year-old female with a three-week history of COVID-19 infection who presented with symmetric polyneuropathy in bilateral lower extremities that progressed to involve bilateral upper extremities and skeletal muscles of respiration, resulting in respiratory distress and necessitating intubation and mechanical ventilation. Cerebrospinal fluid (CSF) analysis revealed albumino-cytologic dissociation, and our patient met the National Institute of Neurological Disorders and Strokes (NINDS) criteria for diagnosing Guillain-Barré Syndrome, making GBS to be the most likely diagnosis. This case report aims to strengthen the association of GBS with COVID-19 infection and describes the hospital course of GBS.
Copyright © 2022, Rane et al.

Entities:  

Keywords:  covid-19; guillain-barre syndrome (gbs); invasive mechanical ventilation; neuromuscular diseases; post covid gbs/ atm; sars-cov-2

Year:  2022        PMID: 35720780      PMCID: PMC9191260          DOI: 10.7759/cureus.25810

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  7 in total

Review 1.  Guillain-Barré syndrome.

Authors:  Nobuhiro Yuki; Hans-Peter Hartung
Journal:  N Engl J Med       Date:  2012-06-14       Impact factor: 91.245

2.  Criteria for diagnosis of Guillain-Barré syndrome.

Authors: 
Journal:  Ann Neurol       Date:  1978-06       Impact factor: 10.422

3.  Campylobacter jejuni infection and Guillain-Barré syndrome.

Authors:  J H Rees; S E Soudain; N A Gregson; R A Hughes
Journal:  N Engl J Med       Date:  1995-11-23       Impact factor: 91.245

4.  Diagnosis of Guillain-Barré syndrome and validation of Brighton criteria.

Authors:  Christiaan Fokke; Bianca van den Berg; Judith Drenthen; Christa Walgaard; Pieter Antoon van Doorn; Bart Casper Jacobs
Journal:  Brain       Date:  2013-10-26       Impact factor: 13.501

5.  Guillain-Barré syndrome associated with SARS-CoV-2 infection: A systematic review and individual participant data meta-analysis.

Authors:  Imran Hasan; K M Saif-Ur-Rahman; Shoma Hayat; Nowshin Papri; Israt Jahan; Rufydha Azam; Gulshan Ara; Zhahirul Islam
Journal:  J Peripher Nerv Syst       Date:  2020-11-05       Impact factor: 3.494

6.  Regional variation of Guillain-Barré syndrome.

Authors:  Alex Y Doets; Christine Verboon; Bianca van den Berg; Thomas Harbo; David R Cornblath; Hugh J Willison; Zhahirul Islam; Shahram Attarian; Fabio A Barroso; Kathleen Bateman; Luana Benedetti; Peter van den Bergh; Carlos Casasnovas; Guido Cavaletti; Govindsinh Chavada; Kristl G Claeys; Efthimios Dardiotis; Amy Davidson; Pieter A van Doorn; Tom E Feasby; Giuliana Galassi; Kenneth C Gorson; Hans-Peter Hartung; Sung-Tsang Hsieh; Richard A C Hughes; Isabel Illa; Badrul Islam; Susumu Kusunoki; Satoshi Kuwabara; Helmar C Lehmann; James A L Miller; Quazi Deen Mohammad; Soledad Monges; Eduardo Nobile Orazio; Julio Pardo; Yann Pereon; Simon Rinaldi; Luis Querol; Stephen W Reddel; Ricardo C Reisin; Nortina Shahrizaila; Soren H Sindrup; Waheed Waqar; Bart C Jacobs
Journal:  Brain       Date:  2018-10-01       Impact factor: 13.501

Review 7.  COVID-19-associated Guillain-Barré syndrome: The early pandemic experience.

Authors:  James B Caress; Ryan J Castoro; Zachary Simmons; Stephen N Scelsa; Richard A Lewis; Aditi Ahlawat; Pushpa Narayanaswami
Journal:  Muscle Nerve       Date:  2020-08-11       Impact factor: 3.852

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.